Viewing Study NCT00434798



Ignite Creation Date: 2024-05-05 @ 5:19 PM
Last Modification Date: 2024-10-26 @ 9:30 AM
Study NCT ID: NCT00434798
Status: UNKNOWN
Last Update Posted: 2008-06-05
First Post: 2007-02-06

Brief Title: Campylobacter Jejuni Challenge Model Development Dose Ranging Study
Sponsor: University of Vermont
Organization: University of Vermont

Study Overview

Official Title: Campylobacter Jejuni Challenge Model Development Dose Ranging Study
Status: UNKNOWN
Status Verified Date: 2008-06
Last Known Status: ACTIVE_NOT_RECRUITING
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: The primary objective of this study is to establish a human Campylobacter jejuni infection model with the following characteristics

1 Safe application

1 Infectious period risk mitigated by close monitoring and prospectively applied early treatment criteria
2 Potential post-infectious sequelae risk mitigated by appropriate strain and host selection
2 Campylobacteriosis attack rate of at least 75

Secondary objectives are to determine humoral cell-mediated and mucosal immune responses in the newly established human C jejuni infection model and evaluate short-term 3 mo protection upon repeat exposure to homologous C jejuni strain and assess immune responses associated with protection
Detailed Description: None

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None